Eleven years intraoperative ATG bolus. A list of successes.
Induction therapy for organ transplantation using monoclonal antibodies has been in recent years reevaluated. Results from various centers indicate the value of such therapy, especially in sensitized patients undergoing kidney transplantation as well as in simultaneous kidney--pancreas transplant patients. Author presents the experience of eleven years of intraoperative ATG bolus administration in the Berlin--Friedrichshain Kidney Transplantation Center.
Kaden
Jürgen
J
Friedrichshain Hospital, Berlin, Germany.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000917:Antibody Formation; D000918:Antibody Specificity; D000961:Antilymphocyte Serum / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007430:Intraoperative Care; D016030:Kidney Transplantation / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents